Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +2.52% | -12.86% | +4.27% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar Clearside Biomedical, Inc.
Upcoming events on Clearside Biomedical, Inc.
Past events on Clearside Biomedical, Inc.
2024-05-14 09:30 am | Citizens JMP Life Sciences Conference |
2024-05-09 04:30 pm | Q1 2024 Earnings Call |
2024-05-09 04:05 pm | Q1 2024 Earnings Release |
2024-04-10 03:00 pm | Needham Healthcare Conference |
2024-03-12 04:30 pm | Q4 2023 Earnings Call |
2024-03-12 04:05 pm | Q4 2023 Earnings Release |
2023-11-15 08:35 am | Stifel Healthcare Conference - Fireside Chat |
2023-11-13 04:30 pm | Q3 2023 Earnings Call |
2023-11-13 04:05 pm | Q3 2023 Earnings Release |
2023-11-06 02:54 pm | American Academy of Ophthalmology Meeting - Poster No PA069 |
2023-11-05 07:09 pm | American Academy of Ophthalmology Meeting - Poster No PA051 |
2023-11-03 06:53 pm | American Academy of Ophthalmology Meeting - Poster No RET10 |
2023-11-02 | American Academy Of Ophthalmology Meeting - Poster No PO603 |
2023-11-02 | American Academy Of Ophthalmology Meeting - Poster No PO514 |
2023-10-10 02:00 pm | JonesTrading Healthcare Summit - Pnnel |
2023-09-26 02:10 pm | Cantor Global Healthcare Conference - Panel |
2023-08-16 07:00 am | H.C. Wainwright Ophthalmology Virtual Conference |
2023-08-14 04:30 pm | Q2 2023 Earnings Call |
2023-08-14 04:05 pm | Q2 2023 Earnings Release |
2023-08-07 02:30 pm | BTIG Virtual Biotechnology Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,17 3,27 -33.51% | 7,89 7,59 4.01% | 29,6 21,3 38.65% | 1,33 1,09 21.3% | 8,23 6,13 34.22% | 0,58 |
EBITDA Million USD | Released Forecast Spread | -30,1 -32,6 7.7% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -30,3 -30,2 -0.32% | -17,9 -19,3 7.18% | -0,63 -11,8 94.68% | -30,3 -30,0 -1.07% | -24,8 -25,9 4.11% | -35,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,8 -30,9 0.27% | -18,2 -19,5 6.75% | 0,38 -12,3 103.06% | -32,9 -30,8 -6.81% | -32,5 -33,5 2.93% | -42,9 |
Net income Million USD | Released Forecast Spread | -30,8 -29,9 -2.84% | -18,2 -16,9 -7.78% | 0,38 -7,28 105.16% | -32,9 -30,8 -6.81% | -32,5 -32,9 1.27% | -42,2 |
EPS USD | Released Forecast Spread | -0,81 -0,81 0.49% | -0,39 -0,35 -12.23% | 0,01 -0,16 106.1% | -0,55 -0,51 -7.32% | -0,53 -0,53 0.75% | -0,57 |
Announcement Date | 11/03/20 | 10/03/21 | 10/03/22 | 09/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,35 6,20 -94.4% | 0,38 0,30 28% | 0,27 0,02 1082.22% | 0,33 0,10 244.47% | 0,00 0,06 -93.33% | 1,02 0,07 1402.58% | 0,86 0,13 549.77% | 6,35 4,24 49.65% | 0,23 0,68 -66.24% | 0,12 | 0,12 | 0,12 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,65 -0,82 -829.04% | -7,84 -7,72 -1.52% | -6,72 -8,34 19.35% | -8,07 -7,75 -4.11% | -7,61 -7,90 3.78% | -7,27 -8,28 12.22% | -7,05 -8,50 17% | -2,92 -3,99 26.89% | -8,21 -8,56 4.11% | -8,93 | -8,99 | -9,18 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,64 1,11 -788.65% | -7,81 -7,81 -0.07% | -7,83 -8,34 6.1% | -9,66 -7,56 -27.86% | -9,28 -8,57 -8.27% | -9,11 -8,62 -5.69% | -9,27 -9,55 2.95% | -4,83 -5,80 16.69% | -11,8 -9,96 -18.06% | -10,3 | -10,3 | -10,6 | ||
Net income Million USD | Released Forecast Spread | -7,64 -0,39 -1843.41% | -7,81 -8,04 2.86% | -7,83 -8,50 7.93% | -9,66 -7,56 -27.86% | -9,28 -8,57 -8.27% | -9,11 -8,74 -4.14% | -9,27 -9,32 0.61% | -4,83 -5,24 7.79% | -11,8 -10,0 -17.6% | -9,77 | -9,88 | -10,0 | ||
EPS USD | Released Forecast Spread | -0,13 -0,12 -11.43% | -0,13 -0,14 3.7% | -0,13 -0,14 7.14% | -0,16 -0,12 -30.61% | -0,15 -0,14 -7.14% | -0,15 -0,14 -4.65% | -0,15 -0,15 -1.69% | -0,08 -0,09 6.98% | -0,17 -0,14 -23.19% | -0,13 | -0,13 | -0,13 | -0,13 | -0,14 |
Announcement Date | 11/05/22 | 09/08/22 | 09/11/22 | 09/03/23 | 12/05/23 | 14/08/23 | 13/11/23 | 12/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Clearside Biomedical, Inc.
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLSD Stock
- Calendar Clearside Biomedical, Inc.